[Featured Stock] Samsung Biologics Rises Ahead of JPM Healthcare Conference
Samsung Biologics is showing strength ahead of its participation in the world's largest bio investment event, the JPM Healthcare Conference.
![[Featured Stock] Samsung Biologics Rises Ahead of JPM Healthcare Conference](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
As of 10 a.m. on the 7th, Samsung Biologics is trading at 1,002,000 KRW, up 5.92% from the previous session.
The anticipation for the JPM Healthcare Conference, which will open from the 13th to the 16th (local time) in San Francisco, USA, is believed to be driving this.
At this event, CEO John Rim will introduce this year's business plans, mid-to-long-term vision, and the background of the company's growth.
During the event, Samsung Biologics will focus on strengthening networking to expand its business by promoting its Contract Development and Manufacturing Organization (CDMO) competitiveness through investor meetings.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Wallets Open Wide on Big News...300 Trillion Won Heads to the U.S., "Tax Breaks" Fail to Keep Funds at Home
- "Realizing How Fast Money Disappears: Should You Try Only the Essentials for 5,000 Won? [The Basics of Benefits]"
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
The JPM Healthcare Conference, held every January, is the largest investment event in the pharmaceutical and bio industry. This year marks its 43rd edition, with around 550 related companies and approximately 8,000 participants expected to attend.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
